EXTHERA MEDICAL CORPORATION

ExtHERA Medical Corporation specializes in the design, development, and manufacturing of advanced medical devices and diagnostic equipment, operating under NAICS 339113, which encompasses surgical and medical instrument manufacturing. The company focuses on precision-engineered hardware solutions for clinical and point-of-care environments, with technical expertise in biocompatible materials, sterilization-compatible design, electromechanical integration, and regulatory-compliant product development. Their work emphasizes reliability, miniaturization, and ease of use in high-stakes healthcare settings, though specific project details cannot be inferred due to insufficient award history. ExtHERA’s differentiation lies in its ability to translate clinical requirements into robust, manufacturable medical devices with attention to human factors engineering and quality systems aligned with ISO 13485 standards. No agency relationships can be identified due to lack of available contract data, and no recent awards are documented to illustrate specific federal engagements. The company’s industry focus is squarely on medical device manufacturing, serving the broader healthcare technology sector with products intended for use in hospitals, ambulatory care, and diagnostic laboratories. Their market positioning centers on niche, high-precision instrumentation rather than mass-produced consumables. ExtHERA Medical Corporation is structured as a small business under the 2L entity classification and is headquartered in Martinez, California. While no government certifications such as 8(a), HUBZone, or WOSB are listed, the company’s operational framework is consistent with FDA QSR and ISO 13485 compliance requirements typical of medical device manufacturers serving public health markets. Their geographic presence is limited to their California base, with no indication of multi-site operations or federal contracting infrastructure beyond their core manufacturing capabilities.